• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Lung Cancer Global Clinical Trials Review, H2, 2012 - Product Image

Lung Cancer Global Clinical Trials Review, H2, 2012

  • ID: 2366136
  • December 2012
  • Region: Global
  • 254 pages
  • GlobalData

Lung Cancer Global Clinical Trials Review, H2, 2012

Summary

Our clinical trial report, “Lung Cancer Global Clinical Trials Review, H2, 2012" provides data on the Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, READ MORE >

Note: Product cover images may vary from those shown

List of Tables
List of Figures
Introduction
Lung Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Lung Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Lung Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Sanofi
Clinical Trial Overview of Sanofi
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Bayer AG
Clinical Trial Overview of Bayer AG
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Merck KGaA
Clinical Trial Overview of Merck KGaA
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Daiichi Sankyo Company, Limited
Clinical Trial Overview of Daiichi Sankyo Company, Limited
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Zhejiang Beta Pharma Inc.
Clinical Trial Overview of Zhejiang Beta Pharma Inc.
ImClone LLC
Clinical Trial Overview of ImClone LLC
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
University of Wisconsin Madison
Clinical Trial Overview of University of Wisconsin Madison
Stanford University
Clinical Trial Overview of Stanford University
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Wake Forest University
Clinical Trial Overview of Wake Forest University
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
Fox Chase Cancer Center
Clinical Trial Overview of Fox Chase Cancer Center
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Kyoto University
Clinical Trial Overview of Kyoto University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, BRIC Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, G7 Countries, 2012-
Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Lung Cancer Therapeutics Clinical Trials, E7 Countries, 2012-
Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Lung Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Lung Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Lung Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhejiang Beta Pharma Inc., 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012-
Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012-

List of Figures
Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012-
Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
Lung Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Lung Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012-
Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Lung Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012-
Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos